Home

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP

CIK 1333817 · last filed 2020-12-01

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP is a corporate insider who has filed 8 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for MDGL, was dated Dec 1, 2020. Across all open-market trades the lifetime net is −$88.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.30B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.30B

Companies

4

Total Filings

8

Lifetime Open-Market Net

-$88.33M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MDGL 10%+ Owner 2,354,058 $553.48 $1.30B $0 2 2020-12-01
NEVRO CORP (NVRO) Delisted 1,688,976 $5.84 $9.86M -$94.31M 1 2015-06-17
ReShape Weightloss Inc. (ETRM) Delisted 10%+ Owner 4,800,964 — — $5.76M 2 2011-09-26
PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted 10%+ Owner 5,279,110 — — $226.9K 2 2007-08-31

Recent Filings

8 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-12-01 MDGL Other (J) −174,148 $0 EDGAR
2020-09-04 MDGL Other (J) −6,181,840 $0 EDGAR
2015-06-17 NEVRO CORP (NVRO) Delisted Sell (S) −1,967,340 -$94.31M EDGAR
2011-09-26 ReShape Weightloss Inc. (ETRM) Delisted Buy (P) +3,360,000 $5.54M EDGAR
2010-11-16 — Buy (P) — $0
2008-10-28 ReShape Weightloss Inc. (ETRM) Delisted Buy (P) +198,400 $218.2K EDGAR
2007-08-31 PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted Buy (P) +19,752 $113.5K EDGAR
2007-08-16 PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted Buy (P) +20,664 $113.4K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.